Bridging the gap between in vitro and in vivo toxicology testing

Alternatives to Laboratory Animals

Volumn 31, Issue 3, 2003, Pages 267-271

  Ehrich, Marion ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

MPTP; Neuroblastoma cells; Neurotoxicity; Organophosphorus compounds

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; ESTERASE; ORGANOPHOSPHORUS COMPOUND;

ANIMAL CELL; CONCENTRATION RESPONSE; CONFERENCE PAPER; EMBRYO; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SPINAL GANGLION; TOXICITY TESTING;

ANIMALIA;

EID: 0043198231     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290303100308     Document Type: Conference Paper

References (27)

1. Ehrich, M. & Veronesi, B. (1999). In vitro neurotoxicology. In Neurotoxicology, 2nd edition (ed. H.A. Tilson & G.J. Harry), pp. 37-51. Philadelphia, PA, USA: Taylor & Francis.
2. Rowles, T.K., Song, X. & Ehrich, M. (1995). Identification of endpoints affected by exposure of human neuroblastoma cells to neurotoxicants at concentrations below those that affect cell viability. In Vitro Toxicology 8, 3-13.
3. Chambers, J.E. & Levi, P.E. (1992). Organophosphates, Chemistry, Fate, and Effects, 443pp. San Diego, CA, USA: Academic Press.
4. Ehrich, M. & Jortner, B.S. (2001). Organophosphorus-induced delayed neuropathy. In Handbook of Pesticide Toxicology: Agents (ed. R. Krieger), pp. 987-1012. San Diego, CA, USA: Academic Press.
5. Tipton, K.R. & Singer, T.P. (1993). Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. Journal of Neurochemistry 61, 1191-1206.
6. Przedborski, S., Jackson-Lewis, V., Naini, A.B., Jakowec, M., Petzinger, G., Miller, R. & Akram, M. (2001). The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. Journal of Neurochemistry 76, 1265-1274.
7. Johannessen, J.N., Chiueh, C.C., Burns, R.S. & Markey, S.P. (1985). Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sciences 36, 219-224.
8. Carlson, K. & Ehrich, M. (2000). Human neuroblastoma cell viability and growth are affected by altered culture conditions. In Vitro and Molecular Toxicology 13, 249-262.
9. Ehrich, M., Correll, L., Carlson, K., Wilcke, J. & Veronesi, B. (1995). Examination of culture conditions on esterase activities in human and mouse neuroblastoma cells. In Vitro Toxicology 8, 199-207.
10. Ehrich, M., Correll, L. & Veronesi, B. (1997). Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundamental and Applied Toxicology 38, 55-63.
11. Correll, L. & Ehrich, M. (1991). A microassay method for neurotoxic esterase determinations. Fundamental and Applied Toxicology 16, 110-116.
12. Carlson, K. & Ehrich, M. (1999). Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicology and Applied Pharmacology 160, 33-42.
13. Carlson, K. & Ehrich, M. (2001). Organophosphorus compounds alter intracellular F-actin content in SH-SY5Y human neuroblastoma cells. Neurotoxicology 22, 819-827.
14. Carlson, K., Jortner, B.S. & Ehrich, M. (2000). Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells. Toxicology and Applied Pharmacology 168, 102-113.
15. Massicotte, C., Jortner, B.S. & Ehrich, M. (2003). Morphological effects of neuropathy-inducing organo-phosphorus compounds in primary dorsal root ganglia cell cultures. Neurotoxicology, in press.
16. Song, X. & Ehrich, M. (1997). MPTP affects cholinergic parameters in SH-SY5Y human neuroblastoma cells. In Vitro Toxicology 10, 437-453.
17. + in SH-SY5Y human neuroblastoma cells. In Vitro and Molecular Toxicology 11, 3-14.
18. Song, X. & Ehrich, M. (1998). MPTP-induced modulation of neurotransmitters in SH-SY5Y human neuroblastoma cells. International Journal of Toxicology 17, 677-701.
19. Song, X., Perkins, S., Jortner, B.S. & Ehrich, M. (1997). Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells. Neurotoxicology 18, 341-354.
20. Song, X. & Ehrich, M. (1997). Alterations of cytoskeletal tau protein of SH-SY5Y human neuroblastoma cells after exposure to MPTP. Neurotoxicology 19, 76-82.
21. Nostrandt, A.C., Rowles, T.K. & Ehrich, M. (1992). Cytotoxic effects of organophosphorus esters and other neurotoxic chemicals on cultured cells. In Vitro Toxicology 5, 127-136.
22. Ehrich, M., Correll, L. & Veronesi, B. (1994). Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Neurotoxicology 15, 309-314.
23. Barber, D.S. & Ehrich, M. (2001). Esterase inhibition in SH-SY5Y human neuroblastoma cells following exposure to organophosphorus compounds for 28 days. In Vitro and Molecular Toxicology 14, 129-135.
24. Barber, D., Correll, L. & Ehrich, M. (1999). Comparison of two in vitro activation systems for protoxicant organophosphorus esterase inhibitors. Toxicological Sciences 47, 16-22.
25. Barber, D., Correll, L. & Ehrich, M. (1999). Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. Journal of Toxicology and Environmental Health 57A, 63-74.
26. United States Environmental Protection Agency (1991). Pesticide Assessment Guidelines, Subdivision E. Hazard Evaluation: Human and Domestic Animals. Addendum 10: Neurotoxicity, series 81, 82 and 83. Office of Prevention, Pesticides and Toxic Substances. Washington, DC. EPA 540/09-1-123. Springfield, VA, USA: NTIS.
27. Jortner, B.S., Barber, D., Perkins, S.K., Hinckley, J. & Ehrich, M. (1999). Morphologic study of nonlethal cytopathic effects of parathion and paraoxon in SH-SY5Y human neuroblastoma cells. Toxicological Sciences 48, Suppl. 1, 184.